|
GB1051723A
(enExample)
|
1962-04-27 |
|
|
|
|
US3202654A
(en)
|
1962-04-27 |
1965-08-24 |
Bristol Myers Co |
6-[alpha-hydroxy-and alpha-amino-alpha-pyrrolylacetamido] penicillanic acids and salts thereof
|
|
US3252970A
(en)
|
1963-02-27 |
1966-05-24 |
Ciba Geigy Corp |
Aromatization
|
|
BE631632A
(enExample)
|
1963-04-26 |
|
|
|
|
US3268558A
(en)
|
1964-11-05 |
1966-08-23 |
Ortho Pharma Corp |
1-r-2, 4-dinitropyrroles
|
|
US3458515A
(en)
|
1966-07-21 |
1969-07-29 |
American Home Prod |
Piperazine substituted pyrroles
|
|
GB1208014A
(en)
|
1967-03-23 |
1970-10-07 |
Glaxo Lab Ltd |
Cephalosporins
|
|
US3573294A
(en)
|
1968-03-14 |
1971-03-30 |
Glaxo Lab Ltd |
7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives
|
|
BE790747A
(fr)
|
1971-10-30 |
1973-02-15 |
Whitefin Holding Sa |
Stereo-isomeres du 1-(1'-(0-chloro-benzyl)-pyrrol-2'-yl) -2-dibutyl sec.-amino-ethanol et procede pour leur preparation
|
|
GB1476503A
(en)
|
1973-06-21 |
1977-06-16 |
Sterling Drug Inc |
1-arylamino-and 1-arylimino-pyrroles and preparation thereof
|
|
BE848465A
(fr)
|
1976-11-18 |
1977-03-16 |
|
Stereo-isomeres de 1-(1'-benzyl-2' pyrryl)-2-disec.butylaminoethanols a activite analgesique et preparations pharmaceutiques qui les contiennent
|
|
US4316900A
(en)
|
1977-10-05 |
1982-02-23 |
Ciba-Geigy Corporation |
Piperazinopyrrolobenzodiazepines
|
|
JPS57142966A
(en)
|
1981-02-27 |
1982-09-03 |
Sagami Chem Res Center |
(1-alkyl-2-pyrrolyl)glyoxylic acid amide derivative
|
|
JPS57144255A
(en)
|
1981-03-03 |
1982-09-06 |
Sagami Chem Res Center |
Alpha-methylthio(1-alkyl-2-pyrrolyl)acetamide derivative
|
|
US4761424A
(en)
|
1985-10-01 |
1988-08-02 |
Warner-Lambert Company |
Enolamides, pharmaceutical compositions and methods for treating inflammation
|
|
FR2601368B1
(fr)
|
1986-07-08 |
1989-04-07 |
Synthelabo |
Derives de nitrofuranne, leur preparation et leur application en therapeutique.
|
|
AU650953B2
(en)
|
1991-03-21 |
1994-07-07 |
Novartis Ag |
Inhaler
|
|
US5637592A
(en)
|
1994-07-12 |
1997-06-10 |
Janssen Pharmaceutica N.V. |
Acyl derivatives of azolones
|
|
HUT77867A
(hu)
|
1994-07-21 |
1998-09-28 |
Eli Lilly And Co. |
sPLA2-gátló indolizinszármazékok és az ezeket tartalmazó gyógyszerkészítmények
|
|
EP0823423B1
(en)
|
1995-04-28 |
2004-06-16 |
Banyu Pharmaceutical Co., Ltd. |
1,4-disubstituted piperidine derivatives
|
|
EP0747756B1
(en)
|
1995-06-06 |
2000-05-24 |
Agfa-Gevaert N.V. |
Photographic materials
|
|
JPH09249669A
(ja)
|
1996-03-13 |
1997-09-22 |
Ono Pharmaceut Co Ltd |
縮合ピロール誘導体、およびそれらを有効成分として含有する薬剤
|
|
ES2210769T3
(es)
|
1997-06-13 |
2004-07-01 |
Cydex Inc. |
Compuesto con vida de almacenamiento prolongada que comprende ciclodextrina y medicamentos y promedicamentos que se descomponen en componentes insolubles en agua.
|
|
ATE364374T1
(de)
|
1997-08-11 |
2007-07-15 |
Pfizer Prod Inc |
Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit
|
|
KR20010052487A
(ko)
|
1998-06-03 |
2001-06-25 |
쥐피아이 엔아이엘 홀딩스 인코포레이티드 |
신경계 질환 및 탈모 치료에 사용되는 아자-헤테로고리화합물
|
|
US6331537B1
(en)
|
1998-06-03 |
2001-12-18 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
|
|
EP1027887B1
(en)
|
1999-02-10 |
2008-08-13 |
Pfizer Products Inc. |
Matrix controlled release device
|
|
CA2372691C
(en)
|
1999-05-04 |
2009-11-17 |
Janssen Pharmaceutica N.V. |
Antifungal ethers
|
|
AU6438800A
(en)
|
1999-07-30 |
2001-02-19 |
Norbert Heske |
Cannula system for introducing endoscopic tools in a human or animal body
|
|
CZ20022047A3
(cs)
|
1999-12-23 |
2003-09-17 |
Pfizer Products Inc. |
Farmaceutické kompozice poskytující zvýšenou koncentraci léčiva
|
|
GB0011089D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Gastrin and cholecystokinin receptor ligands (11)
|
|
US7202239B2
(en)
|
2001-04-12 |
2007-04-10 |
Wyeth |
Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
|
|
US6825201B2
(en)
|
2001-04-25 |
2004-11-30 |
Bristol-Myers Squibb Company |
Indole, azaindole and related heterocyclic amidopiperazine derivatives
|
|
WO2002098876A1
(en)
|
2001-06-06 |
2002-12-12 |
Vertex Pharmaceuticals Incorporated |
Cak inhibitors and uses thereof
|
|
CA2451605C
(en)
|
2001-06-20 |
2010-08-10 |
Daiichi Pharmaceutical Co., Ltd. |
Diamine derivatives
|
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
EP1469830A2
(en)
|
2002-02-01 |
2004-10-27 |
Pfizer Products Inc. |
Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
|
|
WO2003063822A2
(en)
|
2002-02-01 |
2003-08-07 |
Pfizer Products Inc. |
Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
|
|
US20040162298A1
(en)
|
2002-02-23 |
2004-08-19 |
Hsu-Tso Ho |
Method of treating HIV infection by preventing interaction of CD4 and gp120
|
|
EP1543841A4
(en)
|
2002-08-15 |
2011-03-16 |
Yunqing Liu |
SOLID PHARMACEUTICAL NANO FORMULATION AND MANUFACTURING METHOD THEREFOR
|
|
US20050032871A1
(en)
|
2002-09-03 |
2005-02-10 |
Sugen, Inc. |
Sulfonylated pyrrole-2-indolinone derivatives as kinase inhibitors
|
|
AU2004222387A1
(en)
|
2003-03-13 |
2004-09-30 |
Synta Pharmaceuticals Corp. |
Fused pyrrole compounds
|
|
FR2854079B1
(fr)
|
2003-04-25 |
2007-11-30 |
Pf Medicament |
Procede de preparation de complexes moleculaires
|
|
CL2004001884A1
(es)
|
2003-08-04 |
2005-06-03 |
Pfizer Prod Inc |
Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
|
|
AU2004284084A1
(en)
|
2003-10-24 |
2005-05-06 |
Schering Aktiengesellschaft |
Indolinone derivatives and their use in treating disease-states such as cancer
|
|
WO2005115330A2
(en)
|
2004-05-28 |
2005-12-08 |
Pfizer Products Inc. |
Pharmaceutical compositions with enhanced performance
|
|
US20060058286A1
(en)
|
2004-09-16 |
2006-03-16 |
Mark Krystal |
Methods of treating HIV infection
|
|
US8617604B2
(en)
|
2005-02-03 |
2013-12-31 |
Bend Research, Inc. |
Pharmaceutical compositions with enhanced performance
|
|
NZ562034A
(en)
|
2005-03-31 |
2009-10-30 |
Janssen Pharmaceutica Nv |
Bicyclic pyrazole compounds as antibacterial agents
|
|
AR053713A1
(es)
|
2005-04-20 |
2007-05-16 |
Xenon Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos como agentes terapeuticos
|
|
CA2608977C
(en)
|
2005-05-18 |
2014-09-23 |
F2G Ltd |
Antifungal agents
|
|
EP1907347A2
(en)
|
2005-07-12 |
2008-04-09 |
Arcadia Pharmaceuticals Inc. |
Compounds with activity at retinoic acid receptors
|
|
WO2007015866A2
(en)
|
2005-07-20 |
2007-02-08 |
Kalypsys, Inc. |
Inhibitors of p38 kinase and methods of treating inflammatory disorders
|
|
GEP20125378B
(en)
|
2006-03-20 |
2012-01-10 |
Vertex Pharma |
Pharmaceutical compositions
|
|
US8343548B2
(en)
|
2006-08-08 |
2013-01-01 |
Shin-Etsu Chemical Co., Ltd. |
Solid dosage form comprising solid dispersion
|
|
US20080118500A1
(en)
|
2006-11-16 |
2008-05-22 |
Taiwan Liposome Company |
Sustained releasing composition via local injection for treating eye diseases
|
|
GB0623209D0
(en)
|
2006-11-21 |
2007-01-03 |
F2G Ltd |
Antifungal agents
|
|
EP2125938A2
(en)
|
2007-01-26 |
2009-12-02 |
Isp Investments Inc. |
Formulation process method to produce spray dried products
|
|
CN101260086B
(zh)
|
2007-03-06 |
2011-08-10 |
中国科学院上海药物研究所 |
蛋白酪氨酸磷酸酯酶1b抑制剂及其制备方法和用途
|
|
GB0710121D0
(en)
|
2007-05-25 |
2007-07-04 |
F2G Ltd |
Antifungal agents
|
|
EP2178518A2
(en)
|
2007-07-13 |
2010-04-28 |
Bend Research, Inc |
Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
|
|
PL2283006T3
(pl)
|
2008-04-24 |
2015-08-31 |
F2G Ltd |
Pirolowe środki przeciwgrzybicze
|
|
GB0809773D0
(en)
|
2008-05-29 |
2008-07-09 |
F2G Ltd |
Antifungal combination therapy
|
|
US20100093872A1
(en)
|
2008-10-15 |
2010-04-15 |
Erimos Pharmaceuticals Llc |
Stable aqueous formulations of water insoluble or poorly soluble drugs
|
|
EA201101568A1
(ru)
|
2009-04-28 |
2012-05-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Лечение ex vivo иммунологических нарушений с помощью ингибиторов pkc-teta
|
|
BR112012031667A2
(pt)
|
2010-06-14 |
2016-11-08 |
Dow Global Technologies Llc |
composição
|
|
US9084976B2
(en)
|
2010-09-03 |
2015-07-21 |
Bend Research, Inc. |
Spray-drying apparatus and methods of using the same
|
|
JPWO2012060448A1
(ja)
|
2010-11-05 |
2014-05-12 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
抗真菌剤としての併用医薬組成物
|
|
US20120308662A1
(en)
|
2011-06-01 |
2012-12-06 |
Nitto Denko Corporation |
Particulate preparation and method for producing the same
|
|
KR101922752B1
(ko)
|
2011-11-29 |
2018-11-27 |
주록스 피티와이 리미티드 |
사이클로덱스트린 및 소수성 약물을 포함하는 주사용 약제학적 조성물을 보존하는 방법
|
|
EP2836205B1
(en)
|
2012-04-11 |
2016-10-19 |
Dow Global Technologies LLC |
Esterified cellulose ethers having a specific substituent distribution
|
|
US9745387B2
(en)
|
2012-08-24 |
2017-08-29 |
Dow Global Technologies Llc |
Partially cross-linked esterified cellulose ethers
|
|
JP6215945B2
(ja)
|
2012-08-24 |
2017-10-18 |
ダウ グローバル テクノロジーズ エルエルシー |
新規ヒドロキシアルキルメチルセルロースアセテートサクシネート
|
|
EA028009B1
(ru)
|
2013-01-22 |
2017-09-29 |
Ф.Хоффманн-Ля Рош Аг |
Фармацевтическая композиция с улучшенной биодоступностью
|
|
EP3865120B1
(en)
|
2013-07-19 |
2025-06-25 |
Boehringer Ingelheim Vetmedica GmbH |
Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
|
|
WO2015007759A1
(en)
|
2013-07-19 |
2015-01-22 |
Boehringer Ingelheim Vetmedica Gmbh |
Etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
|
|
WO2015082562A1
(en)
|
2013-12-05 |
2015-06-11 |
Alrise Biosystems Gmbh |
Process for the production of drug formulations for oral administration
|
|
PT107568B
(pt)
|
2014-03-31 |
2018-11-05 |
Hovione Farm S A |
Processo de secagem por atomização para a produção de pós com propriedades melhoradas.
|
|
EP3415511A1
(en)
|
2014-11-21 |
2018-12-19 |
F2G Limited |
Antifungal agents
|
|
GB201609222D0
(en)
*
|
2016-05-25 |
2016-07-06 |
F2G Ltd |
Pharmaceutical formulation
|